Clinical trials: Bodily Distress Disorder
Anxiety, Neurasthenia
A Study of the Efficacy and Safety of Ranquilon Tablets in Patients With Anxiety in Neurasthenia and Adjustment Disorders
The primary objective of the study is to evaluate the efficacy of Ranquilon, 1 mg tablets, at a dose of 6 mg/day compared to placebo for the treatment of patients with anxiety in neurasthenia and adjustment disorder.
- Conditions
- Anxiety, Neurasthenia, Adjustment Disorders
- Trial name
- NCT05586789
- Testing
- Ranquilon
- Where
- 10 sites in Russia
- Volunteers
- 220 people
- Sponsor
- Valenta Pharm JSC
Anxiety, Neurasthenia
Efficacy and Safety of Ranquilon in Patients With Anxiety Disorders Due to Neurasthenia and Adjustment Disorders
Study is to evaluate the efficacy and safety of the drug Ranquilon, 1 mg tablets, at a dosage of 6 mg/day compared to the drug Afobazole, 10 mg tablets, at a dosage of 30 mg/day for the treatment of patients with anxiety…
- Conditions
- Anxiety, Neurasthenia, Adjustment Disorders
- Trial name
- NCT06843044
- Testing
- Ranquilon, Afobazole
- Where
- 6 sites in Russia
- Volunteers
- 250 people
- Sponsor
- Valenta Pharm JSC